Literature DB >> 28278535

Recent Advances in Uterine Fibroid Etiology.

Michelle M McWilliams1, Vargheese M Chennathukuzhi1.   

Abstract

Uterine fibroids, also known as uterine leiomyoma (UL), are monoclonal tumors of the smooth muscle tissue layer (myometrium) of the uterus. Although ULs are considered benign, uterine fibroids are the source of major quality-of-life issues for approximately 25% of all women, who suffer from clinically significant symptoms of UL. Despite the prevalence of UL, there is no treatment option for UL which is long term, cost-effective, and leaves fertility intact. The lack of understanding about the etiology of UL contributes to the scarcity of medical therapies available. Studies have identified an important role for sex steroid hormones in the pathogenesis of UL, and have driven the use of hormonal treatment for fibroids, with mixed results. Dysregulation of cell signaling pathways, miRNA expression, and cytogenetic abnormalities have also been implicated in UL etiology. Recent discoveries on the etiology of UL and the development of relevant genetically modified rodent models of UL have started to revitalize UL research. This review outlines the major characteristics of fibroids; major contributors to UL etiology, including steroid hormones; and available preclinical animal models for UL. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28278535      PMCID: PMC5490981          DOI: 10.1055/s-0037-1599090

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  112 in total

1.  Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib.

Authors:  Primo N Lara; Jeff Longmate; Philip C Mack; Karen Kelly; Mark A Socinski; Ravi Salgia; Barbara Gitlitz; Tianhong Li; Mariana Koczywas; Karen L Reckamp; David R Gandara
Journal:  Clin Cancer Res       Date:  2015-06-23       Impact factor: 12.531

2.  Early menarcheal age and risk for later depressive symptomatology: the role of childhood depressive symptoms.

Authors:  Sarah R Black; Daniel N Klein
Journal:  J Youth Adolesc       Date:  2012-03-25

Review 3.  The impact of uterine leiomyomas on reproductive outcomes.

Authors:  H Cook; M Ezzati; J H Segars; K McCarthy
Journal:  Minerva Ginecol       Date:  2010-06

4.  In-vitro model of uterine leiomyomas: formation of ball-like aggregates.

Authors:  Y Kobayashi; T Nikaido; Y L Zhai; M Iinuma; T Shiozawa; M Shirota; S Fujii
Journal:  Hum Reprod       Date:  1996-08       Impact factor: 6.918

5.  Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking.

Authors:  L M Marshall; D Spiegelman; J E Manson; M B Goldman; R L Barbieri; M J Stampfer; W C Willett; D J Hunter
Journal:  Epidemiology       Date:  1998-09       Impact factor: 4.822

6.  Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium.

Authors:  Erica E Marsh; Zhihong Lin; Ping Yin; Magdy Milad; Debabrata Chakravarti; Serdar E Bulun
Journal:  Fertil Steril       Date:  2007-09-04       Impact factor: 7.329

7.  Murine xenograft model for human uterine fibroids: an in vivo imaging approach.

Authors:  Guangli Suo; Anil Sadarangani; Babbette Lamarca; Bryan Cowan; Jean Y J Wang
Journal:  Reprod Sci       Date:  2009-06-10       Impact factor: 3.060

8.  Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.

Authors:  Judy S Crabtree; Scott A Jelinsky; Heather A Harris; Sung E Choe; Monette M Cotreau; Michelle L Kimberland; Ewa Wilson; Kathryn A Saraf; Wei Liu; Adrienne S McCampbell; Bhuvanesh Dave; Russell R Broaddus; Eugene L Brown; Wenling Kao; Jerauld S Skotnicki; Magid Abou-Gharbia; Richard C Winneker; Cheryl L Walker
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

9.  The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.

Authors:  Nasser Chegini; Xiaoping Luo; Li Ding; Daylene Ripley
Journal:  Mol Cell Endocrinol       Date:  2003-11-14       Impact factor: 4.102

10.  Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle.

Authors:  E A Stewart; A J Friedman; K Peck; R A Nowak
Journal:  J Clin Endocrinol Metab       Date:  1994-09       Impact factor: 5.958

View more
  31 in total

1.  A-Kinase Anchoring Protein 13 (AKAP13) Augments Progesterone Signaling in Uterine Fibroid Cells.

Authors:  Sinnie Sin Man Ng; Soledad Jorge; Minnie Malik; Joy Britten; Szu-Chi Su; Charles R Armstrong; Joshua T Brennan; Sydney Chang; Kimberlyn Maravet Baig; Paul H Driggers; James H Segars
Journal:  J Clin Endocrinol Metab       Date:  2019-03-01       Impact factor: 5.958

2.  Cross-talk between miR-29c and transforming growth factor-β3 is mediated by an epigenetic mechanism in leiomyoma.

Authors:  Tsai-Der Chuang; Omid Khorram
Journal:  Fertil Steril       Date:  2019-12       Impact factor: 7.329

3.  Effects of Phthalate Esters on Human Myometrial and Fibroid Cells: Cell Culture and NOD-SCID Mouse Data.

Authors:  Hyun Jin Kim; Sung Hoon Kim; Young Sang Oh; Seung-Ho Heo; Kang-Hyun Kim; Do Young Kim; Sa Ra Lee; Hee Dong Chae
Journal:  Reprod Sci       Date:  2020-10-09       Impact factor: 3.060

Review 4.  Importance of Fibrosis in the Pathogenesis of Uterine Leiomyoma and the Promising Anti-fibrotic Effects of Dipeptidyl Peptidase-4 and Fibroblast Activation Protein Inhibitors in the Treatment of Uterine Leiomyoma.

Authors:  Anusha Shreenidhi Bhat; Ningthoujam Anirudh Singh; Emdormi Rymbai; Swapna Birendra; Saravanan Jayaram; Divakar Selvaraj
Journal:  Reprod Sci       Date:  2022-08-15       Impact factor: 2.924

5.  Non-hormonal mediators of uterine fibroid growth.

Authors:  Esra Cetin; Ayman Al-Hendy; Michał Ciebiera
Journal:  Curr Opin Obstet Gynecol       Date:  2020-10       Impact factor: 1.927

Review 6.  Macrophages and Immune Responses in Uterine Fibroids.

Authors:  Alessandro Zannotti; Stefania Greco; Pamela Pellegrino; Federica Giantomassi; Giovanni Delli Carpini; Gaia Goteri; Andrea Ciavattini; Pasquapina Ciarmela
Journal:  Cells       Date:  2021-04-22       Impact factor: 6.600

7.  Epigenomic tensor predicts disease subtypes and reveals constrained tumor evolution.

Authors:  Jacob R Leistico; Priyanka Saini; Christopher R Futtner; Miroslav Hejna; Yasuhiro Omura; Pritin N Soni; Poorva Sandlesh; Magdy Milad; Jian-Jun Wei; Serdar Bulun; J Brandon Parker; Grant D Barish; Jun S Song; Debabrata Chakravarti
Journal:  Cell Rep       Date:  2021-03-30       Impact factor: 9.995

8.  Robotic single-site versus multi-port myomectomy: a case-control study.

Authors:  So Hyun Ahn; Joo Hyun Park; Hye Rim Kim; SiHyun Cho; Myeongjee Lee; Seok Kyo Seo; Young Sik Choi; Byung Seok Lee
Journal:  BMC Surg       Date:  2021-05-27       Impact factor: 2.102

Review 9.  Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.

Authors:  Seiichi Mori; Osamu Gotoh; Kazuma Kiyotani; Siew Kee Low
Journal:  J Hum Genet       Date:  2021-06-07       Impact factor: 3.172

10.  MicroRNA-139-5p Regulates Fibrotic Potentials via Modulation of Collagen Type 1 and Phosphorylated p38 MAPK in Uterine Leiomyoma.

Authors:  So Hyun Ahn; Heeyon Kim; Inha Lee; Jae Hoon Lee; SiHyun Cho; Young Sik Choi
Journal:  Yonsei Med J       Date:  2021-08       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.